(Q35053171)

6 August 2017

1 reference

title

Small- and large-scale biosimulation applied to drug discovery and development (English)

1 reference

6 August 2017

1 reference

C J Musante

1

1 reference

6 August 2017

Annette K Lewis

series ordinal

2

1 reference

6 August 2017

Kevin Hall

series ordinal

3

1 reference

6 August 2017

publication date

1 October 2002

1 reference

6 August 2017

1 reference

6 August 2017

volume

7

1 reference

6 August 2017

issue

20 Suppl

1 reference

6 August 2017

page(s)

S192-6

1 reference

Biological simulations in drug discovery

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

Minimal model for determination of insulin sensitivity: repeatability in control and obese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

Assessment of insulin sensitivity in man: a comparison of minimal model- and euglycaemic clamp-derived measures in health and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

The oral glucose minimal model: estimation of insulin sensitivity from a meal test

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

Modelling viral and immune system dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

Modeling the heart--from genes to cells to the whole organ

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

Effects of an antibody to interleukin-5 in a monkey model of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902442-X

7 January 2021

10.1016/S1359-6446(02)02442-X

Identifiers

DOI

1 reference

6 August 2017

1 reference